Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvs save search
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published: 2024-04-17 (Crawled : 10:00) - prnewswire.com
TMO | News | $542.82 0.24% 190K
|
Health Technology
|
| O: -0.26%
H: 0.03%
C: -1.55%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.87%
H: 0.16%
C: -0.59%
RGNX | $15.99 -0.75% 82K
|
Health Technology
|
| O: -1.43%
H: 2.27%
C: -3.18%
global dna market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published: 2024-04-17 (Crawled : 06:00) - globenewswire.com
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.87%
H: 0.16%
C: -0.59%
kesimpta sclerosis novartis show benefits
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published: 2024-04-16 (Crawled : 14:00) - prnewswire.com
VTRS | $11.2 0.72% 1M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: -1.24%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
PHG | $20.1 0.6% 120K
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
VRNA | $16.04 -0.37% 55K
|
Health Technology
|
| O: 1.65%
H: 2.43%
C: 0.87%
reach treatment research market
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
REGN | $901.745 0.87% 87K
|
Health Technology
|
| O: -1.94%
H: 0.43%
C: -0.34%
OCUL | News | $5.07 -13.48% 2.6M
|
Health Technology
|
| O: -1.03%
H: 3.66%
C: 1.7%
ocular key leaders
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.75%
H: 0.85%
C: 0.85%
AZNCF | $138.24 -1.36% 0
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: -2.52%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
BAX | $39.965 0.79% 220K
|
Health Technology
|
| O: -0.1%
H: 0.13%
C: -1.08%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.32%
H: 0.96%
C: 0.22%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
BMRN S | $89.63 -0.49% 190K
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
AZN | $68.505 0.21% 580K
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
set therapeutics market
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
fabhalta nephropathy for novartis show
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.32%
H: 0.04%
C: -0.56%
ARVN | $34.135 -0.45% 33K
|
Health Technology
|
| O: 8.28%
H: 0.56%
C: -4.75%
arv-766 protac license cancer treatment global protein for commercialization agreement
Novartis tender offer for MorphoSys AG commences
Published: 2024-04-11 (Crawled : 09:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.32%
H: 0.48%
C: -0.17%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.32%
H: 0.04%
C: -0.56%
MOR | $18.0 -0.28% 33K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.39%
for novartis
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published: 2024-04-10 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.17 16K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -0.29%
H: 0.0%
C: -1.97%
VTRS | $11.2 0.72% 1M
|
Health Technology
|
| O: -0.6%
H: 1.03%
C: 0.52%
TMO | News | $542.82 0.24% 190K
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
JAZZ | $109.715 0.41% 24K
|
Health Technology
|
| O: -1.71%
H: 0.57%
C: 0.37%
disorders system set market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF | $138.24 -1.36% 0
|
Health Technology
|
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS | $11.2 0.72% 1M
|
Health Technology
|
| O: -0.25%
H: 1.1%
C: -0.17%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: -0.05%
H: 0.43%
C: -0.27%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -0.35%
BHC | $8.69 1.05% 400K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
AZN | $68.505 0.21% 580K
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: 0.19%
eczema dermatitis set therapeutics market
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published: 2024-04-06 (Crawled : 20:20) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.43 0.93% 220K
|
Health Technology
| Email alert
Add to watchlist
leqvio novartis therapy show
Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published: 2024-04-03 (Crawled : 06:00) - prnewswire.com
CAJPY | News | $28.42 29K
|
n/a
|
| O: -0.3%
H: 0.54%
C: 0.54%
CAJFF | News | $29.0664 760
|
Electronic Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.86%
H: 0.17%
C: 0.17%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.04%
H: 0.46%
C: -0.08%
PHG | $20.1 0.6% 120K
|
Health Technology
|
| O: 1.0%
H: 0.0%
C: 0.0%
worldwide set market
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
NAMS | $19.97 2.73% 23K
|
n/a
|
| O: 6.23%
H: 2.77%
C: -10.21%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.47%
H: 0.23%
C: -0.99%
pharma business
Carisma Therapeutics Announces Changes to its Board of Directors
Published: 2024-04-01 (Crawled : 11:00) - prnewswire.com
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.47%
H: 0.23%
C: -0.99%
CRIS | $15.07 -0.99% 1.2K
|
Health Technology
|
| O: 0.7%
H: 16.87%
C: 16.87%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published: 2024-03-29 (Crawled : 18:00) - prnewswire.com
BMY | $48.56 0.54% 1.8M
|
Health Technology
| Email alert
Add to watchlist
GILD | News | $66.495 0.51% 1.9M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $265.32 0.98% 550K
|
Health Technology
| Email alert
Add to watchlist
GMAB | $28.67 1.2% 41K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.135 1.64% 270K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.43 0.93% 220K
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 220
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $165.09 0.26% 760K
|
Health Technology
| Email alert
Add to watchlist
research global leukemia therapeutics market
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published: 2024-03-28 (Crawled : 22:00) - prnewswire.com
NVS | $93.43 0.93% 220K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.145 1.78% 1.3M
|
Health Technology
| Email alert
Add to watchlist
ALC | $79.46 1.26% 250K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
one key medical growth market
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published: 2024-03-28 (Crawled : 19:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.43 0.93% 220K
|
Health Technology
| Email alert
Add to watchlist
AVEO | $15.0 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
AUTL | $4.75 -1.04% 49K
|
Health Technology
| Email alert
Add to watchlist
medical
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
antibody research global
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
AZNCF | $138.24 -1.36% 0
|
Health Technology
|
| O: 0.89%
H: 0.78%
C: 0.78%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
ABBV | News | $165.09 0.26% 760K
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
ABT | News | $107.145 1.78% 1.3M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
AZN | $68.505 0.21% 580K
|
Health Technology
|
| O: -0.12%
H: 0.25%
C: -0.63%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
abbvie set canada key market
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ERAS | $1.81 1.12% 58K
|
|
| O: 17.48%
H: 6.94%
C: -14.88%
NVS | $93.43 0.93% 220K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial results
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.